nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR1D—meninx—brain cancer	0.0736	0.0877	CbGeAlD
Oxymetazoline—HTR1B—dura mater—brain cancer	0.0699	0.0834	CbGeAlD
Oxymetazoline—HTR1D—dura mater—brain cancer	0.0677	0.0807	CbGeAlD
Oxymetazoline—HTR2C—choroid plexus—brain cancer	0.057	0.068	CbGeAlD
Oxymetazoline—HTR1B—trigeminal nerve—brain cancer	0.0301	0.0358	CbGeAlD
Oxymetazoline—HTR1D—trigeminal nerve—brain cancer	0.0291	0.0347	CbGeAlD
Oxymetazoline—HTR2A—choroid plexus—brain cancer	0.0286	0.0341	CbGeAlD
Oxymetazoline—NISCH—Podofilox—Etoposide—brain cancer	0.0219	1	CbGdCrCtD
Oxymetazoline—HTR1B—cranial nerve—brain cancer	0.0214	0.0255	CbGeAlD
Oxymetazoline—HTR1D—cranial nerve—brain cancer	0.0207	0.0247	CbGeAlD
Oxymetazoline—HTR1B—telencephalic ventricle—brain cancer	0.0174	0.0208	CbGeAlD
Oxymetazoline—HTR1D—telencephalic ventricle—brain cancer	0.0169	0.0201	CbGeAlD
Oxymetazoline—HTR2C—telencephalic ventricle—brain cancer	0.0167	0.0199	CbGeAlD
Oxymetazoline—HTR2A—trigeminal nerve—brain cancer	0.0145	0.0172	CbGeAlD
Oxymetazoline—HTR2A—cerebellar cortex—brain cancer	0.0144	0.0172	CbGeAlD
Oxymetazoline—HTR2A—vein—brain cancer	0.0131	0.0156	CbGeAlD
Oxymetazoline—HTR1B—ganglion—brain cancer	0.0108	0.0129	CbGeAlD
Oxymetazoline—HTR1D—ganglion—brain cancer	0.0105	0.0125	CbGeAlD
Oxymetazoline—HTR2C—ganglion—brain cancer	0.0104	0.0124	CbGeAlD
Oxymetazoline—HTR2A—cranial nerve—brain cancer	0.0103	0.0123	CbGeAlD
Oxymetazoline—HTR2A—pons—brain cancer	0.0102	0.0121	CbGeAlD
Oxymetazoline—HTR1E—brainstem—brain cancer	0.00997	0.0119	CbGeAlD
Oxymetazoline—HTR1E—telencephalon—brain cancer	0.00884	0.0105	CbGeAlD
Oxymetazoline—HTR1B—blood vessel—brain cancer	0.00862	0.0103	CbGeAlD
Oxymetazoline—HTR2A—telencephalic ventricle—brain cancer	0.00838	0.00999	CbGeAlD
Oxymetazoline—HTR1D—blood vessel—brain cancer	0.00835	0.00995	CbGeAlD
Oxymetazoline—HTR2A—pineal body—brain cancer	0.00727	0.00866	CbGeAlD
Oxymetazoline—NISCH—telencephalon—brain cancer	0.00649	0.00774	CbGeAlD
Oxymetazoline—ADRA1A—hindbrain—brain cancer	0.00612	0.00729	CbGeAlD
Oxymetazoline—HTR1E—head—brain cancer	0.00551	0.00656	CbGeAlD
Oxymetazoline—ADRA1D—telencephalon—brain cancer	0.00542	0.00646	CbGeAlD
Oxymetazoline—NISCH—pituitary gland—brain cancer	0.00529	0.0063	CbGeAlD
Oxymetazoline—HTR2A—ganglion—brain cancer	0.00521	0.00622	CbGeAlD
Oxymetazoline—NISCH—medulla oblongata—brain cancer	0.0051	0.00608	CbGeAlD
Oxymetazoline—HTR1E—central nervous system—brain cancer	0.00503	0.00599	CbGeAlD
Oxymetazoline—HTR1B—brainstem—brain cancer	0.00471	0.00562	CbGeAlD
Oxymetazoline—NISCH—midbrain—brain cancer	0.00466	0.00556	CbGeAlD
Oxymetazoline—HTR1D—brainstem—brain cancer	0.00456	0.00544	CbGeAlD
Oxymetazoline—NISCH—spinal cord—brain cancer	0.00455	0.00542	CbGeAlD
Oxymetazoline—HTR2C—brainstem—brain cancer	0.00452	0.00539	CbGeAlD
Oxymetazoline—HTR2A—endothelium—brain cancer	0.0045	0.00536	CbGeAlD
Oxymetazoline—HTR1B—telencephalon—brain cancer	0.00418	0.00499	CbGeAlD
Oxymetazoline—HTR2A—blood vessel—brain cancer	0.00415	0.00494	CbGeAlD
Oxymetazoline—HTR1D—telencephalon—brain cancer	0.00405	0.00483	CbGeAlD
Oxymetazoline—HTR2C—telencephalon—brain cancer	0.00401	0.00478	CbGeAlD
Oxymetazoline—HTR1E—brain—brain cancer	0.00399	0.00476	CbGeAlD
Oxymetazoline—HTR2A—hindbrain—brain cancer	0.00395	0.00471	CbGeAlD
Oxymetazoline—HTR2B—telencephalon—brain cancer	0.00377	0.00449	CbGeAlD
Oxymetazoline—NISCH—cerebellum—brain cancer	0.00361	0.0043	CbGeAlD
Oxymetazoline—ADRA1A—brainstem—brain cancer	0.00351	0.00418	CbGeAlD
Oxymetazoline—ADRA1B—head—brain cancer	0.00345	0.00411	CbGeAlD
Oxymetazoline—ADRA1D—endocrine gland—brain cancer	0.00342	0.00407	CbGeAlD
Oxymetazoline—ADRA1D—head—brain cancer	0.00337	0.00402	CbGeAlD
Oxymetazoline—HTR2C—medulla oblongata—brain cancer	0.00315	0.00376	CbGeAlD
Oxymetazoline—ADRA1B—central nervous system—brain cancer	0.00315	0.00375	CbGeAlD
Oxymetazoline—ADRA1A—telencephalon—brain cancer	0.00311	0.00371	CbGeAlD
Oxymetazoline—ADRA1D—central nervous system—brain cancer	0.00308	0.00367	CbGeAlD
Oxymetazoline—HTR1B—midbrain—brain cancer	0.003	0.00358	CbGeAlD
Oxymetazoline—ADRA2C—telencephalon—brain cancer	0.00297	0.00353	CbGeAlD
Oxymetazoline—HTR1B—spinal cord—brain cancer	0.00293	0.00349	CbGeAlD
Oxymetazoline—NISCH—brain—brain cancer	0.00293	0.00349	CbGeAlD
Oxymetazoline—HTR1D—midbrain—brain cancer	0.00291	0.00347	CbGeAlD
Oxymetazoline—HTR2C—midbrain—brain cancer	0.00288	0.00343	CbGeAlD
Oxymetazoline—HTR2C—spinal cord—brain cancer	0.00281	0.00335	CbGeAlD
Oxymetazoline—HTR1B—endocrine gland—brain cancer	0.00264	0.00315	CbGeAlD
Oxymetazoline—HTR1B—head—brain cancer	0.0026	0.00311	CbGeAlD
Oxymetazoline—HTR1D—head—brain cancer	0.00252	0.00301	CbGeAlD
Oxymetazoline—ADRA1B—brain—brain cancer	0.0025	0.00298	CbGeAlD
Oxymetazoline—HTR2C—head—brain cancer	0.0025	0.00298	CbGeAlD
Oxymetazoline—ADRA1D—brain—brain cancer	0.00244	0.00291	CbGeAlD
Oxymetazoline—ADRA2C—pituitary gland—brain cancer	0.00241	0.00288	CbGeAlD
Oxymetazoline—HTR1B—central nervous system—brain cancer	0.00238	0.00283	CbGeAlD
Oxymetazoline—ADRA2A—telencephalon—brain cancer	0.00237	0.00282	CbGeAlD
Oxymetazoline—HTR2B—head—brain cancer	0.00235	0.0028	CbGeAlD
Oxymetazoline—ADRA2C—medulla oblongata—brain cancer	0.00233	0.00278	CbGeAlD
Oxymetazoline—HTR1D—central nervous system—brain cancer	0.0023	0.00274	CbGeAlD
Oxymetazoline—HTR2C—central nervous system—brain cancer	0.00228	0.00272	CbGeAlD
Oxymetazoline—HTR2A—brainstem—brain cancer	0.00227	0.0027	CbGeAlD
Oxymetazoline—HTR2B—central nervous system—brain cancer	0.00214	0.00255	CbGeAlD
Oxymetazoline—ADRA2C—midbrain—brain cancer	0.00213	0.00254	CbGeAlD
Oxymetazoline—ADRA2C—spinal cord—brain cancer	0.00208	0.00248	CbGeAlD
Oxymetazoline—HTR2A—telencephalon—brain cancer	0.00201	0.0024	CbGeAlD
Oxymetazoline—ADRA2A—gonad—brain cancer	0.00197	0.00235	CbGeAlD
Oxymetazoline—ADRA1A—endocrine gland—brain cancer	0.00196	0.00234	CbGeAlD
Oxymetazoline—ADRA1A—head—brain cancer	0.00194	0.00231	CbGeAlD
Oxymetazoline—ADRA2A—pituitary gland—brain cancer	0.00193	0.0023	CbGeAlD
Oxymetazoline—HTR1B—brain—brain cancer	0.00189	0.00225	CbGeAlD
Oxymetazoline—ADRA2A—medulla oblongata—brain cancer	0.00186	0.00222	CbGeAlD
Oxymetazoline—ADRA2C—head—brain cancer	0.00185	0.0022	CbGeAlD
Oxymetazoline—HTR1D—brain—brain cancer	0.00183	0.00218	CbGeAlD
Oxymetazoline—HTR2C—brain—brain cancer	0.00181	0.00216	CbGeAlD
Oxymetazoline—ADRA1A—central nervous system—brain cancer	0.00177	0.00211	CbGeAlD
Oxymetazoline—ADRA1A—cerebellum—brain cancer	0.00173	0.00206	CbGeAlD
Oxymetazoline—HTR2B—brain—brain cancer	0.0017	0.00203	CbGeAlD
Oxymetazoline—ADRA2A—midbrain—brain cancer	0.0017	0.00203	CbGeAlD
Oxymetazoline—ADRA2C—central nervous system—brain cancer	0.00169	0.00201	CbGeAlD
Oxymetazoline—HTR2A—gonad—brain cancer	0.00168	0.002	CbGeAlD
Oxymetazoline—ADRA2A—spinal cord—brain cancer	0.00166	0.00198	CbGeAlD
Oxymetazoline—ADRA2C—cerebellum—brain cancer	0.00165	0.00196	CbGeAlD
Oxymetazoline—HTR2A—pituitary gland—brain cancer	0.00164	0.00195	CbGeAlD
Oxymetazoline—HTR2A—medulla oblongata—brain cancer	0.00158	0.00188	CbGeAlD
Oxymetazoline—ADRA2A—endocrine gland—brain cancer	0.00149	0.00178	CbGeAlD
Oxymetazoline—ADRA2A—head—brain cancer	0.00147	0.00176	CbGeAlD
Oxymetazoline—HTR2A—midbrain—brain cancer	0.00144	0.00172	CbGeAlD
Oxymetazoline—HTR2A—spinal cord—brain cancer	0.00141	0.00168	CbGeAlD
Oxymetazoline—ADRA1A—brain—brain cancer	0.0014	0.00167	CbGeAlD
Oxymetazoline—ADRA2A—central nervous system—brain cancer	0.00134	0.0016	CbGeAlD
Oxymetazoline—ADRA2C—brain—brain cancer	0.00134	0.00159	CbGeAlD
Oxymetazoline—ADRA2A—cerebellum—brain cancer	0.00131	0.00157	CbGeAlD
Oxymetazoline—HTR2A—endocrine gland—brain cancer	0.00127	0.00151	CbGeAlD
Oxymetazoline—HTR2A—head—brain cancer	0.00125	0.00149	CbGeAlD
Oxymetazoline—HTR2A—central nervous system—brain cancer	0.00114	0.00136	CbGeAlD
Oxymetazoline—HTR2A—cerebellum—brain cancer	0.00112	0.00133	CbGeAlD
Oxymetazoline—ADRA2A—brain—brain cancer	0.00107	0.00127	CbGeAlD
Oxymetazoline—HTR2A—brain—brain cancer	0.000908	0.00108	CbGeAlD
Oxymetazoline—HTR1B—GPCR downstream signaling—IL2—brain cancer	5.75e-05	0.000413	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SHH—brain cancer	5.72e-05	0.000411	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	5.71e-05	0.00041	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—VEGFA—brain cancer	5.7e-05	0.000409	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PDGFRA—brain cancer	5.65e-05	0.000406	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	5.62e-05	0.000404	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SPP1—brain cancer	5.6e-05	0.000402	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HES1—brain cancer	5.57e-05	0.0004	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TRPC6—brain cancer	5.51e-05	0.000396	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SPP1—brain cancer	5.48e-05	0.000394	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NOTCH2—brain cancer	5.48e-05	0.000394	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	5.47e-05	0.000392	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VAV1—brain cancer	5.44e-05	0.000391	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—IL2—brain cancer	5.44e-05	0.000391	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SMO—brain cancer	5.42e-05	0.000389	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTCH1—brain cancer	5.42e-05	0.000389	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—IL2—brain cancer	5.4e-05	0.000388	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	5.38e-05	0.000386	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	5.37e-05	0.000386	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	5.33e-05	0.000383	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—IL2—brain cancer	5.33e-05	0.000383	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PDGFRA—brain cancer	5.31e-05	0.000381	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	5.26e-05	0.000378	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	5.25e-05	0.000377	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VAV1—brain cancer	5.23e-05	0.000375	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—IL2—brain cancer	5.22e-05	0.000375	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HES1—brain cancer	5.19e-05	0.000372	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—RELA—brain cancer	5.16e-05	0.00037	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SPP1—brain cancer	5.15e-05	0.00037	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—ERBB2—brain cancer	5.12e-05	0.000368	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VAV1—brain cancer	5.09e-05	0.000365	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IRS2—brain cancer	5.07e-05	0.000364	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—IL2—brain cancer	5.02e-05	0.000361	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VAV1—brain cancer	5e-05	0.000359	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IRS2—brain cancer	4.96e-05	0.000356	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	4.94e-05	0.000355	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—IL2—brain cancer	4.9e-05	0.000352	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	4.89e-05	0.000351	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	4.88e-05	0.00035	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SPP1—brain cancer	4.79e-05	0.000344	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	4.78e-05	0.000343	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NOTCH2—brain cancer	4.76e-05	0.000342	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HES1—brain cancer	4.68e-05	0.000336	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	4.66e-05	0.000335	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IRS2—brain cancer	4.66e-05	0.000335	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL2—brain cancer	4.64e-05	0.000333	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—VEGFA—brain cancer	4.63e-05	0.000332	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—TP53—brain cancer	4.61e-05	0.000331	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL2—brain cancer	4.56e-05	0.000327	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VAV1—brain cancer	4.54e-05	0.000326	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—IL2—brain cancer	4.53e-05	0.000326	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CCND1—brain cancer	4.53e-05	0.000325	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HES1—brain cancer	4.5e-05	0.000323	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CTNNB1—brain cancer	4.48e-05	0.000322	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PIK3CG—brain cancer	4.47e-05	0.000321	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—APC—brain cancer	4.47e-05	0.000321	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	4.46e-05	0.00032	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VAV1—brain cancer	4.45e-05	0.000319	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	4.44e-05	0.000319	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—APC—brain cancer	4.38e-05	0.000315	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PIK3CG—brain cancer	4.38e-05	0.000315	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HES1—brain cancer	4.37e-05	0.000314	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—IL2—brain cancer	4.35e-05	0.000313	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IRS2—brain cancer	4.34e-05	0.000311	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	4.33e-05	0.000311	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SPP1—brain cancer	4.33e-05	0.000311	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HES1—brain cancer	4.3e-05	0.000309	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—TP53—brain cancer	4.3e-05	0.000309	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PDGFRA—brain cancer	4.28e-05	0.000307	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—IL2—brain cancer	4.24e-05	0.000304	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—IL2—brain cancer	4.17e-05	0.000299	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	4.16e-05	0.000299	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SPP1—brain cancer	4.16e-05	0.000298	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VAV1—brain cancer	4.13e-05	0.000297	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL2—brain cancer	4.12e-05	0.000296	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—APC—brain cancer	4.11e-05	0.000295	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PIK3CG—brain cancer	4.11e-05	0.000295	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	4.1e-05	0.000294	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—EGFR—brain cancer	4.08e-05	0.000293	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SPP1—brain cancer	4.04e-05	0.00029	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—EGFR—brain cancer	3.99e-05	0.000287	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SPP1—brain cancer	3.98e-05	0.000286	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL2—brain cancer	3.95e-05	0.000284	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—VEGFA—brain cancer	3.95e-05	0.000283	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IRS2—brain cancer	3.91e-05	0.000281	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—STAT3—brain cancer	3.91e-05	0.000281	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HES1—brain cancer	3.9e-05	0.00028	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PIK3CG—brain cancer	3.86e-05	0.000277	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL2—brain cancer	3.85e-05	0.000276	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	3.83e-05	0.000275	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—APC—brain cancer	3.83e-05	0.000275	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HES1—brain cancer	3.82e-05	0.000275	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL2—brain cancer	3.79e-05	0.000272	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—IL2—brain cancer	3.78e-05	0.000272	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IRS2—brain cancer	3.76e-05	0.00027	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—EGFR—brain cancer	3.75e-05	0.000269	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PDGFRA—brain cancer	3.72e-05	0.000267	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—IL2—brain cancer	3.7e-05	0.000266	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IRS2—brain cancer	3.66e-05	0.000263	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	3.64e-05	0.000261	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—MYC—brain cancer	3.63e-05	0.000261	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SPP1—brain cancer	3.61e-05	0.000259	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IRS2—brain cancer	3.6e-05	0.000258	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HES1—brain cancer	3.55e-05	0.000255	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—EGFR—brain cancer	3.55e-05	0.000255	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SPP1—brain cancer	3.53e-05	0.000254	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—TP53—brain cancer	3.5e-05	0.000251	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—RELA—brain cancer	3.5e-05	0.000251	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—EGFR—brain cancer	3.49e-05	0.00025	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—ERBB2—brain cancer	3.47e-05	0.000249	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—APC—brain cancer	3.46e-05	0.000248	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	3.46e-05	0.000248	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—IL2—brain cancer	3.44e-05	0.000247	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL2—brain cancer	3.43e-05	0.000247	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—RELA—brain cancer	3.42e-05	0.000246	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—ERBB2—brain cancer	3.4e-05	0.000244	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	3.38e-05	0.000243	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL2—brain cancer	3.36e-05	0.000241	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—APC—brain cancer	3.32e-05	0.000238	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3CG—brain cancer	3.32e-05	0.000238	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SPP1—brain cancer	3.28e-05	0.000236	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IRS2—brain cancer	3.26e-05	0.000234	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	3.23e-05	0.000232	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—APC—brain cancer	3.23e-05	0.000232	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—RELA—brain cancer	3.22e-05	0.000231	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IRS2—brain cancer	3.2e-05	0.000229	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—ERBB2—brain cancer	3.19e-05	0.000229	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	3.18e-05	0.000228	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—APC—brain cancer	3.18e-05	0.000228	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—EGFR—brain cancer	3.15e-05	0.000226	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL2—brain cancer	3.15e-05	0.000226	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CG—brain cancer	3.14e-05	0.000225	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL2—brain cancer	3.12e-05	0.000224	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL2—brain cancer	3.08e-05	0.000221	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CCND1—brain cancer	3.07e-05	0.00022	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CTNNB1—brain cancer	3.04e-05	0.000218	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—EGFR—brain cancer	3.02e-05	0.000217	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CCND1—brain cancer	3e-05	0.000216	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—RELA—brain cancer	2.99e-05	0.000215	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TP53—brain cancer	2.98e-05	0.000214	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CTNNB1—brain cancer	2.98e-05	0.000214	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—ERBB2—brain cancer	2.97e-05	0.000213	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IRS2—brain cancer	2.97e-05	0.000213	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—EGFR—brain cancer	2.94e-05	0.000211	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL2—brain cancer	2.9e-05	0.000208	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—EGFR—brain cancer	2.9e-05	0.000208	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CG—brain cancer	2.88e-05	0.000207	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—APC—brain cancer	2.88e-05	0.000207	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CCND1—brain cancer	2.82e-05	0.000203	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—APC—brain cancer	2.82e-05	0.000203	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	2.82e-05	0.000203	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CTNNB1—brain cancer	2.8e-05	0.000201	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RELA—brain cancer	2.7e-05	0.000194	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL2—brain cancer	2.69e-05	0.000193	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—ERBB2—brain cancer	2.68e-05	0.000193	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—VEGFA—brain cancer	2.68e-05	0.000192	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—STAT3—brain cancer	2.65e-05	0.00019	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCND1—brain cancer	2.63e-05	0.000189	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—brain cancer	2.63e-05	0.000189	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	2.62e-05	0.000188	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—APC—brain cancer	2.62e-05	0.000188	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VEGFA—brain cancer	2.62e-05	0.000188	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	2.6e-05	0.000187	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—STAT3—brain cancer	2.59e-05	0.000186	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RELA—brain cancer	2.59e-05	0.000186	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—ERBB2—brain cancer	2.58e-05	0.000185	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—brain cancer	2.57e-05	0.000185	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RELA—brain cancer	2.52e-05	0.000181	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—ERBB2—brain cancer	2.51e-05	0.00018	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RELA—brain cancer	2.48e-05	0.000178	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—ERBB2—brain cancer	2.47e-05	0.000177	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MYC—brain cancer	2.46e-05	0.000177	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VEGFA—brain cancer	2.46e-05	0.000177	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—STAT3—brain cancer	2.44e-05	0.000175	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL2—brain cancer	2.43e-05	0.000175	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MYC—brain cancer	2.41e-05	0.000173	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—brain cancer	2.41e-05	0.000173	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—brain cancer	2.39e-05	0.000172	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCND1—brain cancer	2.37e-05	0.00017	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—brain cancer	2.36e-05	0.000169	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	2.35e-05	0.000169	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL2—brain cancer	2.34e-05	0.000168	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—brain cancer	2.29e-05	0.000164	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCND1—brain cancer	2.28e-05	0.000164	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL2—brain cancer	2.27e-05	0.000163	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—STAT3—brain cancer	2.27e-05	0.000163	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MYC—brain cancer	2.26e-05	0.000163	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CTNNB1—brain cancer	2.26e-05	0.000162	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RELA—brain cancer	2.25e-05	0.000162	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—ERBB2—brain cancer	2.24e-05	0.000161	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL2—brain cancer	2.24e-05	0.000161	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCND1—brain cancer	2.22e-05	0.000159	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—brain cancer	2.21e-05	0.000159	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RELA—brain cancer	2.21e-05	0.000158	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	2.19e-05	0.000158	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—ERBB2—brain cancer	2.19e-05	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCND1—brain cancer	2.18e-05	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	2.16e-05	0.000155	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MYC—brain cancer	2.11e-05	0.000151	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—brain cancer	2.07e-05	0.000148	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—brain cancer	2.06e-05	0.000148	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RELA—brain cancer	2.05e-05	0.000147	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—STAT3—brain cancer	2.05e-05	0.000147	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—ERBB2—brain cancer	2.04e-05	0.000146	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL2—brain cancer	2.03e-05	0.000146	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—brain cancer	2.02e-05	0.000145	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL2—brain cancer	1.99e-05	0.000143	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—brain cancer	1.99e-05	0.000143	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—brain cancer	1.98e-05	0.000142	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCND1—brain cancer	1.98e-05	0.000142	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—STAT3—brain cancer	1.97e-05	0.000141	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CTNNB1—brain cancer	1.96e-05	0.000141	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.94e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—brain cancer	1.93e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.92e-05	0.000138	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—STAT3—brain cancer	1.91e-05	0.000137	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MYC—brain cancer	1.9e-05	0.000137	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.9e-05	0.000136	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.88e-05	0.000135	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—brain cancer	1.86e-05	0.000134	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—brain cancer	1.86e-05	0.000134	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL2—brain cancer	1.85e-05	0.000133	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MYC—brain cancer	1.83e-05	0.000131	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.8e-05	0.000129	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—brain cancer	1.79e-05	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.78e-05	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MYC—brain cancer	1.78e-05	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MYC—brain cancer	1.75e-05	0.000126	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—brain cancer	1.74e-05	0.000125	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—brain cancer	1.73e-05	0.000124	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—brain cancer	1.72e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.71e-05	0.000123	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STAT3—brain cancer	1.71e-05	0.000123	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.69e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.67e-05	0.00012	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MYC—brain cancer	1.59e-05	0.000114	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—brain cancer	1.57e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—brain cancer	1.56e-05	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MYC—brain cancer	1.55e-05	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STAT3—brain cancer	1.55e-05	0.000112	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—brain cancer	1.55e-05	0.000111	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—brain cancer	1.52e-05	0.000109	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—brain cancer	1.5e-05	0.000108	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—brain cancer	1.46e-05	0.000105	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MYC—brain cancer	1.44e-05	0.000104	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—brain cancer	1.44e-05	0.000103	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—brain cancer	1.41e-05	0.000101	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—brain cancer	1.3e-05	9.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—brain cancer	1.28e-05	9.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—brain cancer	1.19e-05	8.51e-05	CbGpPWpGaD
